NasdaqGS - Nasdaq Real Time Price USD
United Therapeutics Corporation (UTHR)
320.87
-3.10
(-0.96%)
As of 11:49:37 AM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 540,727 | 39 |
| Sales | 275,343 | 32 |
| Net Shares Purchased (Sold) | 265,384 | 71 |
| Total Insider Shares Held | 822.74k | -- |
| % Net Shares Purchased (Sold) | 47.60% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| EDGEMOND JAMES Chief Financial Officer | Sale at price 325.54 - 326.34 per share. | Direct | 3,909,893 | Jun 2, 2025 |
| EDGEMOND JAMES Chief Financial Officer | Conversion of Exercise of derivative security at price 117.76 per share. | Direct | 1,413,120 | Jun 2, 2025 |
| MAHON PAUL A General Counsel | Sale at price 311.14 - 317.19 per share. | Direct | 3,476,765 | May 29, 2025 |
| MAHON PAUL A General Counsel | Conversion of Exercise of derivative security at price 117.76 - 135.42 per share. | Direct | 1,418,980 | May 29, 2025 |
| MAHON PAUL A General Counsel | Sale at price 293.31 - 302.02 per share. | Direct | 3,246,150 | May 15, 2025 |
| MAHON PAUL A General Counsel | Conversion of Exercise of derivative security at price 117.76 per share. | Direct | 1,295,360 | May 15, 2025 |
| THOMPSON TOMMY G Director | Sale at price 305.15 per share. | Direct | 762,865 | May 9, 2025 |
| THOMPSON TOMMY G Director | Conversion of Exercise of derivative security at price 175.43 per share. | Direct | 438,575 | May 9, 2025 |
| MAHON PAUL A General Counsel | Sale at price 295.12 - 303.38 per share. | Direct | 3,310,201 | May 1, 2025 |
| MAHON PAUL A General Counsel | Conversion of Exercise of derivative security at price 117.76 per share. | Direct | 1,295,360 | May 1, 2025 |
| DWEK RAYMOND ALLEN Director | Sale at price 285.57 per share. | Direct | 856,710 | Apr 21, 2025 |
| DWEK RAYMOND ALLEN Director | Conversion of Exercise of derivative security at price 175.43 per share. | Direct | 526,290 | Apr 21, 2025 |
| MAHON PAUL A General Counsel | Sale at price 280.35 - 284.69 per share. | Direct | 3,121,543 | Apr 17, 2025 |
| MAHON PAUL A General Counsel | Conversion of Exercise of derivative security at price 117.76 per share. | Direct | 1,295,360 | Apr 17, 2025 |
| DWEK RAYMOND ALLEN Director | Sale at price 285.16 per share. | Direct | 855,480 | Apr 14, 2025 |
| DWEK RAYMOND ALLEN Director | Conversion of Exercise of derivative security at price 175.43 per share. | Direct | 526,290 | Apr 14, 2025 |
| DWEK RAYMOND ALLEN Director | Sale at price 284.55 per share. | Direct | 1,138,200 | Apr 7, 2025 |
| DWEK RAYMOND ALLEN Director | Conversion of Exercise of derivative security at price 175.43 per share. | Direct | 701,720 | Apr 7, 2025 |
| MAHON PAUL A General Counsel | Sale at price 298.00 - 308.08 per share. | Direct | 3,367,984 | Apr 3, 2025 |
| MAHON PAUL A General Counsel | Conversion of Exercise of derivative security at price 117.76 per share. | Direct | 1,295,360 | Apr 3, 2025 |
| THOMPSON TOMMY G Director | Sale at price 318.80 per share. | Direct | 796,990 | Mar 24, 2025 |
| THOMPSON TOMMY G Director | Conversion of Exercise of derivative security at price 175.43 per share. | Direct | 438,575 | Mar 24, 2025 |
| PATUSKY CHRISTOPHER Director | Sale at price 307.73 - 313.77 per share. | Direct | 1,553,585 | Mar 19, 2025 |
| PATUSKY CHRISTOPHER Director | Conversion of Exercise of derivative security at price 175.43 per share. | Direct | 877,150 | Mar 19, 2025 |
| BENKOWITZ MICHAEL President | Sale at price 313.93 - 323.99 per share. | Indirect | 640,184 | Mar 10, 2025 |
| BENKOWITZ MICHAEL President | Conversion of Exercise of derivative security at price 111.00 per share. | Indirect | 222,000 | Mar 10, 2025 |
| ROTHBLATT MARTINE A Chief Executive Officer | Stock Gift at price 0.00 per share. | Indirect | 0 | Mar 7, 2025 |
| MAHON PAUL A General Counsel | Conversion of Exercise of derivative security at price 163.30 per share. | Direct | 1,069,615 | Mar 6, 2025 |
| BENKOWITZ MICHAEL President | Sale at price 308.66 - 318.82 per share. | Indirect | 3,019,736 | Mar 3, 2025 |
| BENKOWITZ MICHAEL President | Conversion of Exercise of derivative security at price 111.00 per share. | Indirect | 1,074,369 | Mar 3, 2025 |
| KURZWEIL RAYMOND C Director | Sale at price 314.25 - 323.53 per share. | Direct | 4,755,151 | Feb 28, 2025 |
| THOMPSON TOMMY G Director | Sale at price 318.34 per share. | Direct | 795,838 | Feb 28, 2025 |
| THOMPSON TOMMY G Director | Conversion of Exercise of derivative security at price 175.43 per share. | Direct | 438,575 | Feb 28, 2025 |
| KURZWEIL RAYMOND C Director | Conversion of Exercise of derivative security at price 175.43 per share. | Direct | 2,631,450 | Feb 28, 2025 |
| BENKOWITZ MICHAEL President | Sale at price 358.67 - 364.27 per share. | Indirect | 3,607,555 | Feb 24, 2025 |
| BENKOWITZ MICHAEL President | Conversion of Exercise of derivative security at price 111.00 per share. | Indirect | 1,110,000 | Feb 24, 2025 |
| MAHON PAUL A General Counsel | Conversion of Exercise of derivative security at price 163.30 per share. | Direct | 1,257,410 | Feb 20, 2025 |
| BENKOWITZ MICHAEL President | Sale at price 366.19 - 374.18 per share. | Indirect | 3,710,499 | Feb 18, 2025 |
| BENKOWITZ MICHAEL President | Conversion of Exercise of derivative security at price 111.00 per share. | Indirect | 1,110,000 | Feb 18, 2025 |
| BENKOWITZ MICHAEL President | Sale at price 345.69 - 352.43 per share. | Indirect | 3,480,642 | Feb 10, 2025 |
| BENKOWITZ MICHAEL President | Conversion of Exercise of derivative security at price 111.00 per share. | Indirect | 1,110,000 | Feb 10, 2025 |
| MAHON PAUL A General Counsel | Conversion of Exercise of derivative security at price 163.30 per share. | Direct | 1,257,410 | Feb 6, 2025 |
| BENKOWITZ MICHAEL President | Sale at price 347.05 - 358.08 per share. | Indirect | 3,536,398 | Feb 3, 2025 |
| BENKOWITZ MICHAEL President | Conversion of Exercise of derivative security at price 111.00 per share. | Indirect | 1,110,000 | Feb 3, 2025 |
| BENKOWITZ MICHAEL President | Sale at price 369.54 - 375.22 per share. | Indirect | 3,707,081 | Jan 27, 2025 |
| BENKOWITZ MICHAEL President | Conversion of Exercise of derivative security at price 111.00 per share. | Indirect | 1,110,000 | Jan 27, 2025 |
| BENKOWITZ MICHAEL President | Sale at price 362.71 - 369.19 per share. | Indirect | 3,649,112 | Jan 21, 2025 |
| BENKOWITZ MICHAEL President | Conversion of Exercise of derivative security at price 111.00 per share. | Indirect | 1,110,000 | Jan 21, 2025 |
| MAHON PAUL A General Counsel | Conversion of Exercise of derivative security at price 163.30 per share. | Direct | 1,257,410 | Jan 16, 2025 |
| BENKOWITZ MICHAEL President | Sale at price 360.85 - 367.99 per share. | Indirect | 3,646,223 | Jan 13, 2025 |
Related Tickers
NBIX Neurocrine Biosciences, Inc.
124.54
+0.02%
RDY Dr. Reddy's Laboratories Limited
15.59
+5.70%
TAK Takeda Pharmaceutical Company Limited
14.94
-0.57%
ZTS Zoetis Inc.
169.12
+0.30%
HLN Haleon plc
11.09
+1.37%
KNSA Kiniksa Pharmaceuticals International, plc
29.01
+0.46%
LNTH Lantheus Holdings, Inc.
79.83
+0.25%
CPIX Cumberland Pharmaceuticals Inc.
5.45
-1.45%
ANIK Anika Therapeutics, Inc.
11.48
-1.46%
ALKS Alkermes plc
31.20
-1.09%